Gastrolaryn® Stick Following Proton Pump Inhibitor Treatment in Patients with Gastroesophageal Reflux Disease: A Multicenter Real-World Observational Survey
Journal of Clinical Medicine · 02.11.2026 · 15 (21) · 8516
DOI: 10.3390/jcm15218516 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 02.11.2026. Verfasst von Giorgio Ciprandi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medicine and Healthcare Science Department, University of Molise, 86100 Campobasso, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Symptom management after proton pump inhibitor (PPI) treatment remains an important issue in gastroesophageal reflux disease (GERD).
Objective
To describe symptom distributions during a sequential PPI and Gastrolaryn® Stick management pathway in routine outpatient practice.
Methods
In a multicenter, prospective observational survey, 263 GERD patient records were collected at baseline (T0) by 17 gastroenterologists. The intended management sequence comprised 8 weeks of esomeprazole 40 mg daily (T0–T1) followed by 8 weeks of Gastrolaryn® Stick (one stick twice daily; T1–T2). Outcomes included GERD Impact Scale (GIS) response distributions and routine-care characteristics. Analyses were descriptive and based on available records at each survey timepoint.
Results
Records were available for 124 patients at T1 (47.1% of baseline) and 112 at T2 (42.6%). Across recorded GIS item responses, the proportion rated “every day” was 12.8%, 0.9%, and 0.3% at T0, T1, and T2, respectively; the corresponding “never” proportions were 24.8%, 44.5%, and 58.4%. These are unpaired, timepoint-specific descriptive summaries and do not establish individual improvement. Investigators submitting records declined from 17 to 11 and 7.
Conclusions
Among available records, symptom-frequency distributions were more favorable at later survey timepoints. Substantial missing follow-up, changing site participation, the lack of a comparator and unavailable patient-level paired analyses prevent causal attribution, assessment of relapse prevention, or definitive conclusions about maintenance effectiveness. The survey nevertheless documents management and follow-up patterns encountered in routine practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medicine and Healthcare Science Department, University of Molise, 86100 Campobasso, Italy.
- Department of Otorhinolaryngology, University Kore, 94100 Enna, Italy.
ORCID-Profile: Giorgio Ciprandi, Ignazio La Mantia
Zitieren
APA
Ciprandi, G., La Mantia, I., & Varricchio, A. (2026). Gastrolaryn® Stick Following Proton Pump Inhibitor Treatment in Patients with Gastroesophageal Reflux Disease: A Multicenter Real-World Observational Survey. Journal of Clinical Medicine, 15(21), 8516. https://doi.org/10.3390/jcm15218516
Vancouver
Ciprandi G, La Mantia I, Varricchio A. Gastrolaryn® Stick Following Proton Pump Inhibitor Treatment in Patients with Gastroesophageal Reflux Disease: A Multicenter Real-World Observational Survey. Journal of Clinical Medicine. 2026;15(21):8516. doi:10.3390/jcm15218516
BibTeX
@article{Ciprandi2026,
author = {Ciprandi, Giorgio and La Mantia, Ignazio and Varricchio, Attilio},
title = {Gastrolaryn® Stick Following Proton Pump Inhibitor Treatment in Patients with Gastroesophageal Reflux Disease: A Multicenter Real-World Observational Survey},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {21},
pages = {8516},
doi = {10.3390/jcm15218516}
}
EUVIMED